Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Solara Active Pharma Sciences Ltd

Pharmaceuticals & Biotechnology | Small Cap

Solara Active Pharma Sciences Ltd Health Insights
Health Score : 4.34Health Score : 4.34

Solara Active Pharma Sciences Ltd, operating in the Healthcare Services sector, shows a mixed financial performance. The company demonstrates strong solvency, indicating a low level of debt relative to its assets and equity. Profitability metrics present a varied picture, with good gross profit and operating margins, but concerning returns on equity and net margins which needs to be addressed. Growth metrics are highly variable, with strong earnings per share growth offset by declines in revenue and asset growth. The company's liquidity position appears strained, so improvements are needed to improve financial flexibility. While efficiency ratios also show need for improvement, the company's solvency ratios are strong.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Solara Active Pharma Sciences Ltd Health Insights
Health Score : 4.34Health Score : 4.34

Solara Active Pharma Sciences Ltd, operating in the Healthcare Services sector, shows a mixed financial performance. The company demonstrates strong solvency, indicating a low level of debt relative to its assets and equity. Profitability metrics present a varied picture, with good gross profit and operating margins, but concerning returns on equity and net margins which needs to be addressed. Growth metrics are highly variable, with strong earnings per share growth offset by declines in revenue and asset growth. The company's liquidity position appears strained, so improvements are needed to improve financial flexibility. While efficiency ratios also show need for improvement, the company's solvency ratios are strong.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

-375.40

Highly Undervalued

Industry Median

28.62

Highly Undervalued
Highly Undervalued

Small Cap Median

27.17

Highly Undervalued

P/E RATIO

-274.68

P/B RATIO

1.63

Undervalued

Industry Median

3.17

Undervalued
Undervalued

Small Cap Median

2.62

Undervalued

P/S RATIO

1.33

Highly Undervalued

Industry Median

3.42

Highly Undervalued
Undervalued

Small Cap Median

2.55

Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Neutral

EV/EBITDA RATIO

10.15

Neutral

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹563.1 as on Jun 20, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 6.00

The growth metrics present a mixed picture. While earnings per share and net income have shown strong growth, revenue and asset growth rates are declining. This suggests that improvements in profitability are driven by cost management rather than top-line expansion. The company should work towards higher revenue growth.

PoorRevenue Growth RatePoor
PoorOperating Profit Growth RatePoor
ExcellentEarnings Per Share (EPS) GrowthExcellent
PoorAsset Growth RatePoor
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate-21.5813.88-10.73-0.396.62
Operating Profit Growth Rate-79.0265.43-170.9-316.84-9.22
Earnings Per Share (EPS) Growth-126.2-61.852458.66-100.13-1466.67
Asset Growth Rate12.66-1.56-18.9-5.064.53
Net Income Growth Rate-126.24-62.072477.27-100.18-800
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 2.20

The financial metrics indicate challenges in profitability and shareholder returns. Negative adjusted and cash earnings per share suggest losses. The book value per share is low, while dividend per share is minimal. These issues are offset by strong solvency ratios. The company needs to focus on improving its financial metrics.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
PoorCash Earnings Per Share (Cash EPS)Poor
WeakBook Value Per ShareWeak
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)-15-6.11-113.330.25-0.22
Cash Earnings Per Share (Cash EPS)1524.72-128.892520.67
Book Value Per Share423.61416.67259.44273.5278.44
Dividend Per Share (DPS)02.26000
Capital Expenditures (CapEx)209110404052
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 6.60

The profitability ratios indicate a mixed performance. While gross profit and operating margins are healthy, returns on equity and net margins are concerning. The company demonstrates an ability to control costs but struggles to convert revenue into net profit. Company needs to focus on increasing the profitability.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
PoorReturn on Equity (ROE)Poor
WeakReturn on Assets (ROA)Weak
ExcellentOperating MarginExcellent
PoorNet MarginPoor
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin-2.441.59-15.368.336.36
Return on Capital Employed (ROCE)02-965
Return on Equity (ROE)-3.8-1.47-60.710.09-0.56
Return on Assets (ROA)2.754.62-4.049.238.02
Operating Margin6.399.28-7.3716.0413.66
Net Margin-4.57-1.52-43.990.08-0.51
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.67

Efficiency ratios suggest the company is not effectively utilizing its assets. Low turnover ratios for fixed assets, inventory, and receivables indicate slower conversion into sales. High days sales in inventory and receivable days further confirm inefficiencies in working capital management. The company should improve its efficiency.

PoorFixed Asset Turnover RatioPoor
WeakInventory Turnover RatioWeak
WeakReceivables Turnover RatioWeak
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio0.941.061.021.081.11
Inventory Turnover Ratio2.992.53.243.474.03
Receivables Turnover Ratio2.62.812.913.83.57
Days Sales in Inventory Ratio122.07146112.65105.1990.57
Receivable Days140.38129.89125.4396.05102.24
Capital Turnover Ratio0.70.831.231.050.99
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 2.00

The coverage ratios are weak, indicating potential difficulties in meeting interest and dividend obligations. The interest coverage ratio is negative, suggesting an inability to cover interest expenses from earnings. The equity dividend coverage ratio is also low, reflecting limited dividend-paying capacity. The company needs to improve its coverage ratios.

PoorInterest Coverage RatioPoor
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio-0.210.5-3.651.010.93
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits strong solvency, with low debt levels relative to equity and assets. The debt ratio and debt-to-equity ratio are low, indicating a conservative capital structure. The equity ratio is high, reflecting a strong equity base. This strong solvency provides financial stability and flexibility but company need to focus on other ratios as well.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.160.140.110.110.1
Debt to Equity Ratio0.190.160.120.120.11
Equity Ratio0.840.860.890.890.9
Debt To Asset Ratio0.10.090.050.060.06
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 3.08

The liquidity position is weak, suggesting potential difficulties in meeting short-term obligations. The current and cash ratios are poor, indicating insufficient liquid assets to cover current liabilities. The quick ratio is also low, reflecting limited ability to pay off short-term liabilities without relying on inventory. Improvements are needed to enhance financial flexibility.

PoorCurrent RatioPoor
WeakQuick RatioWeak
PoorCash RatioPoor
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.21.120.630.750.94
Quick Ratio0.690.640.360.440.6
Cash Ratio0.040.010.0100.05
Operating Cash Flow Ratio-0.220.140.080.210.16
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 19 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Jagsonpal Pharmaceuticals Ltd8.5133.01Overvalued58.006.4243.00
2Amrutanjan Health Care Ltd8.2577.37Highly Overvalued31.0020.0321.00
3Windlas Biotech Ltd7.5225.92Neutral105.0032.1966.00
4Lincoln Pharmaceuticals Ltd7.3114.01Neutral98.0043.8888.00
5Morepen Laboratories Ltd7.1228.61Neutral126.001.2196.00
6Alembic Ltd7.067.28Undervalued90.004.85317.00
7NGL Fine Chem Ltd6.9839.22Overvalued73.0067.3948.00
8Syncom Formulations (India) Ltd6.9217.27Undervalued77.000.8176.00
9Hester Biosciences Ltd6.5431.74Neutral87.0061.2457.00
10Sigachi Industries Ltd6.4911.55Highly Undervalued54.00-2.08-83.00
11Sakar Healthcare Ltd5.8158.66Highly Overvalued69.0013.7030.00
12Remus Pharmaceuticals Ltd5.3125.48Neutral57.0020.9746.00
13IOL Chemicals & Pharmaceuticals Ltd5.3127.76Undervalued269.004.69138.00
14Indoco Remedies Ltd5.26-22.79Neutral142.00-0.61-99.00
15Ind-Swift Laboratories Ltd4.9539.28Neutral45.004.8941.00
16Venus Remedies Ltd4.8323.37Neutral147.0074.30103.00
17Wanbury Ltd4.6528.62Neutral88.0018.9343.00
18Solara Active Pharma Sciences Ltd4.34-274.68Neutral187.00-1.50-7.00
Management Assessment Summary
OrangeBalanced Management

Solara Active Pharma Sciences' management effectiveness shows a mixed performance. While improved operating profit margins signal better operational efficiency, significant concerns arise from declining compounded profit growth and negative returns on capital employed. The decreased promoter holding could indicate a lack of confidence. Overall, the assessment is flagged as Orange, indicating potential challenges that require careful consideration.

Category Metric Value Assessment
PROS Operating Profit Margin (Dec 2024) 19.21% Improving OPM indicates better operational efficiency.
CONS Compounded Profit Growth (5 Years) -66% Declining profit growth is a significant concern.
Return on Capital Employed (Mar 2024) -9% Negative ROCE indicates inefficient capital use.
Promoter Holding (Mar 2024) 30.49% Decreased promoter holding raises concerns.
WeakFinancial Performance & GrowthWeak
PoorCapital Efficiency & ReturnsPoor
WeakFinancial Health & PrudenceWeak
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
RedWeak Risk

Solara Active Pharma Sciences has high-risk due to its financial performance and operational inefficiencies. Inconsistent profitability, negative ROCE, and high debt levels indicate potential financial strain. Declining promoter holding and fluctuating sales increase these risks. Although some improvements in operating profit margin are noted, the overall risk profile remains concerning.

AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
AverageContingent liability evaluationAverage
01.

Segment performance volatility

02.

Foreign exchange or interest rate exposure

03.

Contingent liability evaluation

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10565.00Bearish
  3. SMA 20571.65Bearish
  4. SMA 50586.10Bearish
  5. EMA 10566.22Bearish
  6. EMA 20571.14Bearish
  7. EMA 50575.41Bearish
  8. DEMA 10561.95Bullish
  9. DEMA 20562.95Bullish
  10. DEMA 50577.65Bearish
  11. TEMA 10563.06Bullish
  12. TEMA 20559.04Bullish
  13. TEMA 50570.06Bearish
  14. MACD-6.11Bearish
  15. ADX14.02Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI35.57Neutral
  3. CCI-69.93Neutral
  4. ROC 9-0.26Bearish
  5. ROC 14-3.07Bearish
  6. ROC 25-3.29Bearish
  7. Stoch K20.80Neutral
  8. Stoch D15.75Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper587.46Neutral
  3. BB Middle571.65Neutral
  4. BB Lower555.84Neutral
  5. ATR6.48Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI24.81Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10569.72Bearish
  3. SMA 20580.98Bearish
  4. SMA 50569.32Bearish
  5. EMA 10569.90Bearish
  6. EMA 20574.77Bearish
  7. EMA 50570.90Bearish
  8. DEMA 10562.60Bullish
  9. DEMA 20571.33Bearish
  10. DEMA 50582.62Bearish
  11. TEMA 10560.63Bullish
  12. TEMA 20562.63Bullish
  13. TEMA 50580.20Bearish
  14. MACD-3.74Bearish
  15. ADX27.84Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI40.58Neutral
  3. CCI-99.65Neutral
  4. ROC 9-2.67Bearish
  5. ROC 14-3.33Bearish
  6. ROC 25-2.92Bearish
  7. Stoch K12.87Oversold
  8. Stoch D8.64Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper607.83Neutral
  3. BB Middle580.98Neutral
  4. BB Lower554.13Neutral
  5. ATR9.91Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI30.70Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10580.18Bearish
  3. SMA 20575.28Bearish
  4. SMA 50561.74Bullish
  5. EMA 10574.35Bearish
  6. EMA 20572.47Bearish
  7. EMA 50557.01Bullish
  8. DEMA 10571.51Bearish
  9. DEMA 20580.54Bearish
  10. DEMA 50584.55Bearish
  11. TEMA 10563.89Bullish
  12. TEMA 20577.26Bearish
  13. TEMA 50N/AN/A
  14. MACD4.96Bearish
  15. ADX41.67Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI47.89Neutral
  3. CCI-52.12Neutral
  4. ROC 9-5.91Bearish
  5. ROC 14-1.62Bearish
  6. ROC 254.76Bullish
  7. Stoch K7.80Oversold
  8. Stoch D19.28Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper618.71Neutral
  3. BB Middle575.28Neutral
  4. BB Lower531.84Neutral
  5. ATR17.65Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI59.35Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10576.94Bearish
  3. SMA 20560.81Bullish
  4. SMA 50530.08Bullish
  5. SMA 100502.25Bullish
  6. SMA 200546.73Bullish
  7. EMA 10572.87Bearish
  8. EMA 20563.14Bearish
  9. EMA 50537.98Bullish
  10. EMA 100527.64Bullish
  11. EMA 200536.92Bullish
  12. DEMA 10580.02Bearish
  13. DEMA 20582.84Bearish
  14. DEMA 50564.84Bearish
  15. DEMA 100527.03Bullish
  16. DEMA 200516.48Bullish
  17. TEMA 10576.41Bearish
  18. TEMA 20582.64Bearish
  19. TEMA 50588.36Bearish
  20. TEMA 100549.75Bullish
  21. TEMA 200505.57Bullish
  22. MACD14.17Bearish
  23. ADX43.46Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI52.18Neutral
  3. CCI10.45Neutral
  4. ROC 142.87Bullish
  5. ROC 2510.91Bullish
  6. Stoch K50.47Neutral
  7. Stoch D59.98Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper606.79Neutral
  3. BB Middle560.81Neutral
  4. BB Lower514.82Neutral
  5. ATR28.58Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI82.96Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20498.49Bullish
  3. SMA 50559.81Bullish
  4. EMA 20525.17Bullish
  5. EMA 50538.52Bullish
  6. DEMA 20526.20Bullish
  7. DEMA 50519.63Bullish
  8. TEMA 20548.50Bullish
  9. TEMA 50500.60Bullish
  10. MACD5.41Bullish
  11. ADX21.84Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI57.58Neutral
  3. CCI25.43Neutral
  4. ROC 1432.57Bullish
  5. ROC 256.06Bullish
  6. Stoch K71.83Neutral
  7. Stoch D69.22Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper586.49Overbought
  3. BB Middle498.49Neutral
  4. BB Lower410.49Neutral
  5. ATR53.77High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI90.01Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6497.90Bullish
  3. SMA 12549.69Bearish
  4. SMA 24584.91Bearish
  5. EMA 6507.34Bullish
  6. EMA 12525.25Bullish
  7. EMA 24536.29Bearish
  8. DEMA 6491.89Bullish
  9. DEMA 12502.16Bullish
  10. DEMA 24524.94Bullish
  11. TEMA 6499.10Bullish
  12. TEMA 12480.63Bullish
  13. TEMA 24532.09Bullish
  14. MACD-6.10Bearish
  15. ADX13.05Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI50.17Neutral
  3. CCI37.36Neutral
  4. ROC 258.53Bullish
  5. ROC 50-13.21Bearish
  6. Stoch K36.31Neutral
  7. Stoch D53.80Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper779.49Neutral
  3. BB Middle568.66Neutral
  4. BB Lower357.83Neutral
  5. ATR116.32Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI74.43Neutral